2017
DOI: 10.1101/183905
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Low-intensity focused ultrasound alters the latency and spatial patterns of sensory-evoked cortical responsesin vivo

Abstract: The use of transcranial, low intensity focused ultrasound (FUS) is an emerging neuromodulation technology that shows promise for both therapeutic and research applications. Compared with other noninvasive neuromodulation approaches, key technical advantages include high lateral resolution of stimulation and deep penetration depth. However, empirically observed effects in vivo are diverse; for example, variations in sonication location and waveform can alternatively elicit putatively inhibitory or excitatory ef… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(10 citation statements)
references
References 62 publications
0
10
0
Order By: Relevance
“…Most of the studies testing for cell damage or death [2,19,21,22,27e30,32e40] did not observe harmful effects of TFUS. One recent study [31] observed no differential GFAP expression between the control and sonicated hemisphere for I sppa ¼ 0.69 W/ cm 2 , suggesting the absence of neural trauma. However, an increased number of astrocytes was observed for a control condition with I sppa ¼ 280 W/cm 2 (~1.5 times above the FDA limit).…”
Section: Cell Damage or Deathmentioning
confidence: 89%
See 4 more Smart Citations
“…Most of the studies testing for cell damage or death [2,19,21,22,27e30,32e40] did not observe harmful effects of TFUS. One recent study [31] observed no differential GFAP expression between the control and sonicated hemisphere for I sppa ¼ 0.69 W/ cm 2 , suggesting the absence of neural trauma. However, an increased number of astrocytes was observed for a control condition with I sppa ¼ 280 W/cm 2 (~1.5 times above the FDA limit).…”
Section: Cell Damage or Deathmentioning
confidence: 89%
“…It is then tested whether TFUS causes the substance to diffuse into brain tissue. The dyes fluorescein isothiocyanate-dextran (FITCdextran) [27], trypan blue [28e30] or Evans blue [31] have been used for this purpose, and their presence inside the brain was investigated in post-mortem microscopy analyses of brain slices. Alternatively, an MRI contrast agent (a gadolinium chelate) was injected before the stimulation and its penetration into brain tissue was tested by assessing the MRI signal change due to the contrast agent [29].…”
Section: Types Of Adverse and Side Effects Caused By Tfusmentioning
confidence: 99%
See 3 more Smart Citations